Literature DB >> 3028808

Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus.

G Nigro, M E Pacella, E Patanè, M Midulla.   

Abstract

A fatal case of Coxsackievirus B-6 (CBV-6) infection in a 4 1/2-year-old girl is reported. The disease was initially characterized by a severe meningoencephalitis and, successively, by the appearance of hyperglycaemia and glycosuria, concomitantly with complement-fixing-islet cell antibodies (CF-ICA) and ICA, diarrhoea, electrolyte disorders, arrhythmia and decrease of the IgG levels, suggesting a multi-system involvement. CBV-6 was identified by isolation from stool and cerebrospinal fluid and by detection of specific IgM antibodies.

Entities:  

Mesh:

Year:  1986        PMID: 3028808     DOI: 10.1007/BF02429065

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Virus-tissue union and the pathogenesis of enterovirus infections.

Authors:  C M KUNIN
Journal:  J Immunol       Date:  1962-05       Impact factor: 5.422

2.  Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism.

Authors:  D R Spriggs; R T Bronson; B N Fields
Journal:  Science       Date:  1983-04-29       Impact factor: 47.728

3.  Enterovirus infections in the neonate.

Authors:  S Krajden; P J Middleton
Journal:  Clin Pediatr (Phila)       Date:  1983-02       Impact factor: 1.168

4.  The mononuclear phagocyte system: role in expression of immunocompetence in neonatal and adult life.

Authors:  R M Blaese; D G Poplack; A V Muchmore
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

5.  Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique.

Authors:  R Dörries; V ter Meulen
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

6.  Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage.

Authors:  G F Bottazzo; B M Dean; A N Gorsuch; A G Cudworth; D Doniach
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

7.  Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus.

Authors:  H F Champsaur; G F Bottazzo; J Bertrams; R Assan; C Bach
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

8.  Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group.

Authors:  A Toniolo; T Onodera; G Jordan; J W Yoon; A L Notkins
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

9.  The location and nature of enterovirus receptors in susceptible cells.

Authors:  J J HOLLAND; L C McLAREN
Journal:  J Exp Med       Date:  1961-08-01       Impact factor: 14.307

10.  Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.

Authors:  J W Yoon; P R McClintock; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  4 in total

1.  Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

Authors:  T M Szopa; T Ward; D M Dronfield; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

2.  Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.

Authors:  Toru Kanno; Kisoon Kim; Ken Kono; Kristen M Drescher; Nora M Chapman; Steven Tracy
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Mononucleosis-like syndrome associated with a multisystem Coxsackie virus type B3 infection in adolescence.

Authors:  J Begovac; V Puntarić; D Borcić; B Barsić; J Zrinscak; I Beus; V Presecki
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

Review 4.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.